山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (7): 118-120.doi: 10.6040/j.issn.1671-7554.0.2023.0237
王蕾1,向淇1,刘学伍1,2
中图分类号:
| [1] Campetella L, Papi C, Sabatelli E, et al. Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neuroimmunol, 2022, 372: 577972. doi: 10.1016/j.jneuroim.2022.577972. [2] Dalmau J, Tüzün E, Wu H, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1): 25-36. [3] Bigi S, Hladio M, Twilt M, et al. The growing spectrum of antibody-associated inflammatory brain diseases in children[J]. Neurol Neuroimmunol Neuroinflamm, 2015, 2(3): e92.doi: 10.1212/NXI.0000000000000092. [4] Hoftberger R, Titulaer M J, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients[J]. Neurology, 2013, 81(17): 1500-1506. [5] Lancaster E, Lai M, Peng X, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen[J]. Lancet Neurol, 2010, 9(1): 67-76. [6] Zhu F, Shan W, Lv R, et al. Clinical characteristics of anti-GABA-B receptor encephalitis[J]. Front Neurol, 2020, 11:403. doi: 10.3389/fneur.2020.00403. [7] Hean V, Camdessanché J, Cathébras P, et al. Paraneoplastic subacute sensory neuropathy with triple positive antineuronal antibodies associated with small-cell lung cancer[J]. BMJ Case Reports, 2020, 13(8): e235668. doi: 10.1136/bcr-2020-235668. [8] Graus F, Dalmau J. Paraneoplastic neurological syndromes[J]. Curr Opin Neurol, 2012, 25(6): 795-801. [9] Abali H, Tokgoz Akyil F, Tural Onur S, et al. Coexistence of multiple pulmonary sclerosing pneumocytoma and scleroderma–rheumatoid arthritis overlap syndrome: a case report[J]. Turk Thorac, 2022, 23(4): 302-305. [10] Haitao R, Huiqin L, Tao Q, et al. Autoimmune encephalitis associated with vitiligo?[J]. J Neuroimmunol, 2017, 310: 14-16. doi: 10.1016/j.jneuroim.2017.05.019. [11] Szucs G, Szekanecz Z, Zilahi E, et al. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity[J]. Rheumatology, 2007, 46(6): 989-993. [12] Bonifazi M, Tramacere I, Pomponio G, et al. Systemic sclerosis(scleroderma)and cancer risk: systematic review and meta-analysis of observational studies[J]. Rheumatology, 2012, 52(1): 143-154. [13] Zhong H, Zhou J, Zhang S, et al. Risk and prognosis factors for systemic sclerosis with lung cancer: A single-centre case-control study in China[J]. Int J Clin Pract, 2021, 75(4): e13819. doi: 10.1111/ijcp.13819. [14] Osarogiagbon R U, Yu X. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer[J]. Ann Thorac Surg, 2013, 96(4): 1178-1189. [15] Colaci M, Giuggioli D, Sebastiani M, et al. Lung cancer in scleroderma: Results from an Italian rheumatologic center and review of the literature[J]. Autoimmun Rev, 2013, 12(3): 374-379. [16] Topuzoglu S, Knobler R, Movadat O, et al. Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis[J]. Photodermatol, Photoimmunol Photomed, 2015, 31(4): 175-183. [17] Morrisroe K, Hansen D, Huq M, et al. Incidence, Risk factors, and outcomes of cancer in systemic sclerosis[J]. Arthritis Care Res, 2020, 72(11): 1625-1635. [18] Sakr L, Hudson M, Wang M, et al. Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group[J]. J Scleroderma Relat Disord, 2018, 3(3): 221-227. [19] Khurana R, Wolf R, Berney S, et al. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans[J]. J Rheumatol, 2008, 35(9): 1704-1708. [20] Peng H, Wu X, Wen Y, et al. Association between systemic sclerosis and risk of lung cancer: results from a pool of cohort studies and Mendelian randomization analysis[J]. Autoimmun Rev, 2020, 19(10): 102633. doi: 10.1016/j.autrev.2020.102633. [21] Wu X, Peng H, Wen Y, et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study[J]. Semin Arthritis Rheum, 2021, 51(3): 565-575. |
| [1] | 王丽. 小剂量泼尼松辅助金匮肾气丸治疗系统性硬化症20例报告[J]. 山东大学学报(医学版), 2209, 47(6): 127-128. |
| [2] | 段盈竹,董波,于睿. 内在情感与类风湿关节炎患者冠状动脉粥样硬化风险关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2026, 64(4): 63-71. |
| [3] | 黄佩文, 王旭东. 治疗非小细胞肺癌新药:靶向c-Met蛋白的抗体药物偶联物Telisotuzumab Vedotin[J]. 山东大学学报 (医学版), 2026, 64(3): 124-130. |
| [4] | 赵汉卿,周新睿,李子建,唐兴. 循环肿瘤细胞联合血清学检测在非小细胞肺癌中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 79-85. |
| [5] | 徐年兴,魏东,乔俊杰,战炳炎. CD8+、IL-6和PaO2对不可切除ⅢB/C和Ⅳ期非小细胞肺癌免疫治疗触发放射召回性肺炎的预测价值[J]. 山东大学学报 (医学版), 2025, 63(2): 29-35. |
| [6] | 山东省腔镜外科质量控制中心胸腔镜委员会. 山东省VATS/RATS非小细胞肺癌围术期质量控制指标专家共识(2025版)[J]. 山东大学学报 (医学版), 2025, 63(12): 1-5. |
| [7] | 宋慧梳,孙志坚,张邱婷,弭雪,张妮,王志仑,尹哲,郝学喜,王迎雪. MiR-125a-3p对类风湿关节炎滑膜成纤维细胞增殖的影响[J]. 山东大学学报 (医学版), 2025, 63(12): 74-78. |
| [8] | 刘振昆,吕纪玲,徐伟伟,马力天,张才擎. BALF tNGS检测及培养对NSCLC合并IPFD的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(11): 36-45. |
| [9] | 张荣雨,赵文,李洪欣,杨闯,王健,韩春燕,李际盛. 奥西替尼联合化疗一线治疗EGFR-RAD51融合突变转移性肺腺癌1例[J]. 山东大学学报 (医学版), 2024, 62(5): 116-120. |
| [10] | 姜任东,赵建莉,时超,贺业腾,袁振. 加速康复外科理念下全膝关节置换治疗类风湿关节炎与骨关节炎患者的临床疗效[J]. 山东大学学报 (医学版), 2024, 62(10): 62-67. |
| [11] | 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82. |
| [12] | 陈兆波,方敏,薛浩然,刘春艳. 去泛素化酶USP35促进非小细胞肺癌细胞迁移和侵袭[J]. 山东大学学报 (医学版), 2022, 60(4): 30-37. |
| [13] | 马瑞杰,朱良明,左太阳,李春海,张楠,孙志钢. 微波消融治疗非小细胞肺癌根治术后肺寡转移瘤的预后分析[J]. 山东大学学报 (医学版), 2022, 60(12): 63-68. |
| [14] | 刘会宁,彭军,任迎春,杨光,王文豪,刘金锋,田勍. 34例胸腔镜下肺楔形切除与21例肺段切除对位于肺段P区的ⅠA1期非小细胞肺癌治疗比较[J]. 山东大学学报 (医学版), 2022, 60(11): 38-43. |
| [15] | 丁子琛,王浩桦,周立雯,丛慧文,李承圣,包绮晗,杨毅,王廉源,王素珍,石福艳. 基于贝叶斯累加回归树模型的非小细胞肺癌患者个性化疗效研究[J]. 山东大学学报 (医学版), 2022, 60(10): 92-98. |
|
||
